BridgeBio Pharma (BBIO) Equity Ratio (2018 - 2026)
BridgeBio Pharma recorded quarterly Equity Ratio of 1.65 in Q1 2026, up 25.79% quarter-over-quarter from 2.23 in Q4 2025, and up 10.99% year-over-year from 1.49 in Q1 2025.
BridgeBio Pharma's Equity Ratio history runs 9 years deep, the most recent figure standing at 1.65 for Q1 2026.
- In Q1 2026, Equity Ratio rose 10.99% year-over-year to 1.65; the TTM figure through Mar 2026 stood at 1.65 (up 10.99% YoY), while the FY2025 annual figure was 2.23, down 40.59% from the prior year.
- Equity Ratio came in at 1.65 for Q1 2026 at BridgeBio Pharma, up from 2.23 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 1.18 in Q2 2022 to a low of 2.68 in Q2 2023.
- A 5-year average of 1.78 and a median of 1.82 in 2023 frame the typical range for Equity Ratio.
- Across the five-year window, Equity Ratio sank 259.48% in 2022 and surged 49.19% in 2024, its largest moves.
- BridgeBio Pharma's Equity Ratio stood at 2.0 in 2022, then declined by 23.17% to 2.46 in 2023, then jumped by 35.49% to 1.59 in 2024, then tumbled by 40.59% to 2.23 in 2025, then increased by 25.79% to 1.65 in 2026.
- According to Business Quant data, Equity Ratio over the past three periods registered 1.65, 2.23, and 1.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 0.21 |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -1.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.65 |
| Dec 31, 2025 | -2.23 |
| Sep 30, 2025 | -1.94 |
| Jun 30, 2025 | -1.65 |
| Mar 31, 2025 | -1.86 |
| Dec 31, 2024 | -1.59 |
| Sep 30, 2024 | -1.83 |
| Jun 30, 2024 | -1.36 |
| Mar 31, 2024 | -1.22 |
| Dec 31, 2023 | -2.46 |
| Sep 30, 2023 | -1.82 |
| Jun 30, 2023 | -2.68 |
| Mar 31, 2023 | -1.94 |
| Dec 31, 2022 | -2.00 |
| Sep 30, 2022 | -1.55 |
| Jun 30, 2022 | -1.18 |
| Mar 31, 2022 | -1.28 |
| Dec 31, 2021 | -0.86 |
| Sep 30, 2021 | -0.95 |
| Jun 30, 2021 | -0.42 |
| Mar 31, 2021 | -0.36 |
| Dec 31, 2020 | 0.15 |
| Sep 30, 2020 | 0.27 |
| Jun 30, 2020 | 0.36 |
| Mar 31, 2020 | 0.45 |
| Dec 31, 2019 | 0.75 |
| Sep 30, 2019 | 0.81 |
| Jun 30, 2019 | 63.92 |
| Dec 31, 2018 | 0.81 |